BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1847694)

  • 21. Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10.
    Shames BD; McIntyre RC; Bensard DD; Pulido EJ; Selzman CH; Reznikov LL; Harken AH; Meng X
    J Surg Res; 2001 Aug; 99(2):187-93. PubMed ID: 11469886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes.
    Geng Y; Zhang B; Lotz M
    J Immunol; 1993 Dec; 151(12):6692-700. PubMed ID: 8258685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-4 suppresses IL-1 beta, TNF-alpha and PGE2 production by human peritoneal macrophages.
    Hart PH; Cooper RL; Finlay-Jones JJ
    Immunology; 1991 Mar; 72(3):344-9. PubMed ID: 2026443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inability of histamine to regulate TNF-alpha production by human alveolar macrophages.
    Rowe J; Finlay-Jones JJ; Nicholas TE; Bowden J; Morton S; Hart PH
    Am J Respir Cell Mol Biol; 1997 Aug; 17(2):218-26. PubMed ID: 9271310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.
    Jovanovic DV; Di Battista JA; Martel-Pelletier J; Jolicoeur FC; He Y; Zhang M; Mineau F; Pelletier JP
    J Immunol; 1998 Apr; 160(7):3513-21. PubMed ID: 9531313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-4 suppression of monocyte tumour necrosis factor-alpha production. Dependence on protein synthesis but not on cyclic AMP production.
    Hart PH; Jones CA; Finlay-Jones JJ
    Immunology; 1992 Aug; 76(4):560-5. PubMed ID: 1328039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells.
    Eigler A; Sinha B; Endres S
    Biochem Biophys Res Commun; 1993 Oct; 196(1):494-501. PubMed ID: 8216333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3',5'-cyclic monophosphate.
    von Bülow V; Rink L; Haase H
    J Immunol; 2005 Oct; 175(7):4697-705. PubMed ID: 16177117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors.
    Bergman MR; Holycross BJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):247-54. PubMed ID: 8859000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells.
    Schindler R; Dinarello CA; Koch KM
    Cytokine; 1995 Aug; 7(6):526-33. PubMed ID: 8580368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor.
    Eigler A; Matschke V; Hartmann G; Erhardt S; Boyle D; Firestein GS; Endres S
    J Leukoc Biol; 2000 Jul; 68(1):97-103. PubMed ID: 10914495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-[2-[4-(2-chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in rat trachea: The involvement of soluble guanylate cyclase and protein kinase G.
    Wu BN; Chen CW; Liou SF; Yeh JL; Chung HH; Chen IJ
    Mol Pharmacol; 2006 Sep; 70(3):977-85. PubMed ID: 16754782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes.
    Caughey GE; Pouliot M; Cleland LG; James MJ
    J Immunol; 1997 Jan; 158(1):351-8. PubMed ID: 8977210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of tumor necrosis factor alpha and interleukin-1 receptor antagonist, but not interleukin-1, by human mononuclear cells is enhanced by exposure of whole blood to shear stress.
    Pomianek MJ; Colton CK; Dinarello CA; Miller LC
    ASAIO J; 1996; 42(1):52-9. PubMed ID: 8808459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines.
    He W; Pelletier JP; Martel-Pelletier J; Laufer S; Di Battista JA
    J Rheumatol; 2002 Mar; 29(3):546-53. PubMed ID: 11908571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Messengers and mediators: interactions among lipids, eicosanoids, and cytokines.
    Endres S
    Am J Clin Nutr; 1993 May; 57(5 Suppl):798S-800S. PubMed ID: 8386434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells.
    Eisenhut T; Sinha B; Gröttrup-Wolfers E; Semmler J; Siess W; Endres S
    Immunopharmacology; 1993; 26(3):259-64. PubMed ID: 7507098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of cyclic-3',5'-nucleotide phosphodiesterase abrogates the synergism of hypoxia with lipopolysaccharide in the induction of macrophage TNF-alpha production.
    Meng X; Ao L; Shames BD; Harken AH
    J Surg Res; 2001 Dec; 101(2):210-5. PubMed ID: 11735278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia.
    Cunha FQ; Teixeira MM; Ferreira SH
    Br J Pharmacol; 1999 Jun; 127(3):671-8. PubMed ID: 10401557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoxygenase inhibitors but not site specific 5-lipoxygenase blockers protect against endotoxic shock and inhibit production of tumor necrosis factor.
    Schade FU; Engel R; Jakobs D
    Eicosanoids; 1992; 5 Suppl():S45-7. PubMed ID: 1449831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.